RIONOXA-60
Enoxaparin Sodium Injection IP 60mg/0.6ml (6000 Anti-factor Xa units) PFS
Product Technical Snapshot
Official pharmaceutical registration and manufacturing parameters
| Brand Name | RIONOXA-60 |
| Active Formulation (Salt) | Enoxaparin Sodium Injection IP 60mg/0.6ml (6000 Anti-factor Xa units) PFS |
| Dosage Form | INJECTIONS |
| Packaging Presentation | 0.6 ml PFS |
| Therapeutic Category | INJECTIONS |
| Regulatory Classification | Schedule H Prescription Drug |
| Pharmacopoeial Standard | IP / BP / USP Pharmacopoeial Standards |
| Quality Certifications | WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility |
| Marketed & Distributed By | Riomedica Healthcare Pvt. Ltd. (Ambala Cantt, Haryana) |
| B2B Franchise Availability | Monopoly PCD Franchise rights available across all Indian districts |
What is RIONOXA-60?
Therapeutic monograph and clinical profile
RIONOXA-60 (Enoxaparin Sodium Injection IP 60mg/0.6ml (6000 Anti-factor Xa units) PFS) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 0.6 ml PFS, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Deep Vein Thrombosis (DVT) & Pulmonary Embolism (PE) / Prophylaxis in Hemodialysis & ACS.
Key Formulation Highlights
Why healthcare professionals recommend RIONOXA-60
Therapeutic Uses & Clinical Indications
Conditions and clinical disorders managed by this medicine
Recommended Clinical Indications:
Deep Vein Thrombosis (DVT) & Pulmonary Embolism (PE) / Prophylaxis in Hemodialysis & ACS
Pharmacological Mechanism of Action
How RIONOXA-60 acts biochemically in the body
Delivers targeted active therapeutic release with rapid absorption and high safety profile.
Dosage & Administration Guidance
Proper usage directions under clinical supervision
As directed by the physician or healthcare professional. Take with water at prescribed intervals.
Precautions, Warnings & Contraindications
Safety guidelines and patient health considerations
Clinical Safety & Medical Advice:
Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.
Possible Side Effects
Tolerability profile and reporting
Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.
Storage & Handling Instructions
Maintaining formulation stability and shelf-life
Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.
Exclusive PCD Pharma Franchise Opportunity for RIONOXA-60
Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for RIONOXA-60 across India with comprehensive visual aids, prompt dispatch, and high profit margins.
Frequently Asked Questions (FAQs)
Common queries regarding RIONOXA-60
What is RIONOXA-60 used for?
What is the active composition of RIONOXA-60?
How can I get monopoly PCD franchise for RIONOXA-60 in my district?
What is the packaging and MRP of RIONOXA-60?
Related Formulations in INJECTIONS
Explore complementary WHO-GMP certified healthcare formulations
